These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 229809)

  • 21. [Experiences with cis-dichlorodiaminoplatinum (II) in the treatment of advanced solid tumors].
    Francesconi M; Breyer S; Mörz R; Rainer H; Moser K
    Acta Med Austriaca Suppl; 1979; 6():334-7. PubMed ID: 299224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin-based chemotherapy for malignant ovarian germ cell tumor.
    Solheim O; Skalleberg J; Warncke T; Ørstavik K; Tropé C; Fosså SD
    Acta Obstet Gynecol Scand; 2019 Feb; 98(2):240-249. PubMed ID: 30289161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial.
    Argyriou AA; Chroni E; Koutras A; Ellul J; Papapetropoulos S; Katsoulas G; Iconomou G; Kalofonos HP
    Neurology; 2005 Jan; 64(1):26-31. PubMed ID: 15642899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Erythropoietin and cisplatin-induced neuropathies in cancer patients].
    Mangiameli A; Spina S; Iannetti E; Catalano D; Spadaro D; Trovato GM
    Clin Ter; 2002; 153(3):177-80. PubMed ID: 12161978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II evaluation of 5-fluorouracil and low-dose leucovorin in cisplatin-refractory advanced ovarian carcinoma.
    Long HJ; Nelimark RA; Su JQ; Garneau SC; Levitt R; Goldberg RM; Poon MA; Kugler JW
    Gynecol Oncol; 1994 Aug; 54(2):180-3. PubMed ID: 8063243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer.
    Scurr LL; Guminski AD; Chiew YE; Balleine RL; Sharma R; Lei Y; Pryor K; Wain GV; Brand A; Byth K; Kennedy C; Rizos H; Harnett PR; deFazio A
    Clin Cancer Res; 2008 Nov; 14(21):6924-32. PubMed ID: 18980987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurotoxicity of intra-arterial cis-platinum (CDDP) in the locoregional treatment of diffuse liver metastasis of carcinoma of the colon and rectum].
    Gori A; Conte PF; Anfossi A
    Minerva Chir; 1990 May; 45(9):663-8. PubMed ID: 2168025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.
    Polyzos A; Kosmas C; Tsavaris N; Toufexi H; Lagadas A; Gogas H; Giannakopoulos K; Kouraklis G; Griniatsos J; Felekouras E; Tsigris C; Nikiteas N; Papadopoulos O; Giannopoulos A
    Anticancer Res; 2007; 27(3B):1645-51. PubMed ID: 17595790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Peripheral neuropathy produced by cisplatin].
    Valero Jiménez P; Murillo Capitán E; Sánchez Romero JA; Arbizu Ladrón de Guevara ML
    Rev Esp Oncol; 1984; 31(3):511-3. PubMed ID: 6085937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
    du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intraperitoneal administration of high doses of cisplatin in advanced ovarian carcinoma].
    Ptácková B; Kopecný J; Zatocil P; Anton M
    Cesk Gynekol; 1989 Mar; 54(2):106-9. PubMed ID: 2731237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase.
    Deng HB; Adikari M; Parekh HK; Simpkins H
    Cancer Chemother Pharmacol; 2004 Oct; 54(4):301-7. PubMed ID: 15138708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral neuropathy as a complication of cis-dichlorodiammineplatinum(II) treatment: a case report.
    Kedar A; Cohen ME; Freeman AI
    Cancer Treat Rep; 1978 May; 62(5):819-21. PubMed ID: 207427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
    Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination chemotherapy of advanced ovarian cancer with hexamethylmelamine, cis-Platinum, and doxorubicin after failure of prior therapy.
    Vogl SE; Pagano M; Kaplan BH; Einhorn N; Arseneau J; Moukhtar M; Greenwald E
    Obstet Gynecol; 1980 Nov; 56(5):635-40. PubMed ID: 6776457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peripheral neuropathy caused by cisplatin in patients with lung cancer].
    Murata M; Yamaji Y; Futami H; Shimada Y; Fujita J; Hashimoto Y; Shiotani T; Irino S
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2283-8. PubMed ID: 2544151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer.
    Roberts JA; Jenison EL; Kim K; Clarke-Pearson D; Langleben A
    Gynecol Oncol; 1997 Nov; 67(2):172-7. PubMed ID: 9367703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [First therapeutic experience with cis-platinum(II)diamindichloride (NSC 119875) in metastasizing ovarian and testicular carcinoma].
    Cavalli F; Sonntag RW; Ryssel HJ; Tschopp L; Brunner KW
    Schweiz Med Wochenschr; 1976 May; 106(22):754-7. PubMed ID: 996494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.
    Wiltshaw E; Kroner T
    Cancer Treat Rep; 1976 Jan; 60(1):55-60. PubMed ID: 1000519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antiemetic effect of methylprednisolone in patients treated with cis-platinum (CDDP) for advanced testicular germ cell tumors.
    Salvioni R; Faustini M; Piva L; Pasi M; Pizzocaro G
    Chemioterapia; 1984 Aug; 3(4):223-6. PubMed ID: 6099753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.